Genentech Drug Patent Portfolio
Genentech owns 4 orange book drugs protected by 7 US patents Given below is the list of Genentech's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9278961 | Pyridyl inhibitors of hedgehog signalling | 15 Dec, 2028 | Active |
| US7888364 | Pyridyl inhibitors of hedgehog signalling | 11 Nov, 2028 | Active |
| US9790183 | Pyridyl inhibitors of hedgehog signalling | 02 Sep, 2025 | Active |
| US5763394 | Human growth hormone aqueous formulation | 09 Jun, 2015 | Expired |
| US5654010 | Composition for sustained release of human growth hormone | 05 Aug, 2014 | Expired |
| US5656297 | Modulated release from biocompatible polymers | 25 Jul, 2014 | Expired |
| US6051259 | Composition for sustained release of human growth hormone | 02 Dec, 2012 | Expired |
Latest Legal Activities on Genentech's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Genentech.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 23 Aug, 2023 | US9278961 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 03 Aug, 2022 | US7888364 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 31 Mar, 2021 | US9790183 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 22 Aug, 2019 | US9278961 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Aug, 2018 | US7888364 |
| Mail O.P. Petition Decision | 11 May, 2018 | US9790183 |
| Mail-Record a Petition Decision of Granted to Issue Patent in Name of the Assignee | 09 May, 2018 | US9790183 |
| O.P. Petition Decision | 08 May, 2018 | US9790183 |
| Record a Petition Decision of Granted to Issue Patent in Name of the Assignee | 08 May, 2018 | US9790183 |
| Post Issue Communication - Certificate of Correction | 08 Nov, 2017 | US9790183 |
| Petition Entered | 31 Oct, 2017 | US9790183 |
|
Recordation of Patent Grant Mailed
Critical
| 17 Oct, 2017 | US9790183 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 17 Oct, 2017 | US9790183 |
|
Email Notification
Critical
| 28 Sep, 2017 | US9790183 |
|
Issue Notification Mailed
Critical
| 27 Sep, 2017 | US9790183 |
Genentech's Family Patents
Genentech Drug List
Given below is the complete list of Genentech's drugs and the patents protecting them.
1. Erivedge
Erivedge is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9278961 | Pyridyl inhibitors of hedgehog signalling |
15 Dec, 2028
(3 years from now)
| Active |
| US7888364 | Pyridyl inhibitors of hedgehog signalling |
11 Nov, 2028
(3 years from now)
| Active |
| US9790183 | Pyridyl inhibitors of hedgehog signalling |
02 Sep, 2025
(7 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Erivedge's drug page
2. Nutropin Aq
Nutropin Aq is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5763394 | Human growth hormone aqueous formulation |
09 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nutropin Aq's drug page
3. Nutropin Aq Pen
Nutropin Aq Pen is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5763394 | Human growth hormone aqueous formulation |
09 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nutropin Aq Pen's drug page
4. Nutropin Depot
Nutropin Depot is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5654010 | Composition for sustained release of human growth hormone |
05 Aug, 2014
(10 years ago)
| Expired |
| US5656297 | Modulated release from biocompatible polymers |
25 Jul, 2014
(10 years ago)
| Expired |
| US6051259 | Composition for sustained release of human growth hormone |
02 Dec, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nutropin Depot's drug page